Research reveals new ways by which prenatal factors can influence lifelong health outcomes. Among these, selective serotonin reuptake inhibitors (SSRIs)—the most common class of antidepressants used during pregnancy—have drawn attention for their potential negative effects on the developing interactions between the gut and the brain.